Rating Update: Stock Rating C-Neutral (3/12/24)-Eagle Pharmaceuticals Inc (EGRX).
BUSINESS Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers […]